首页|中药小分子药物在抗肿瘤免疫中的作用机制研究进展

中药小分子药物在抗肿瘤免疫中的作用机制研究进展

扫码查看
肿瘤免疫治疗已成为目前最有潜力的一种新型抗肿瘤治疗手段,免疫治疗与化疗、靶向等联合方案已成为多种恶性肿瘤的一线治疗方案。中医药在肿瘤综合治疗中具有重要地位,可通过增加免疫细胞数量,改善免疫细胞活性,改善肿瘤免疫微环境,发挥抗肿瘤作用。中药小分子药物种类繁多,具有多靶标、多通路以及药理作用广泛等特点,一直是当前众多肿瘤学者研究的热点领域。大量研究发现,抗肿瘤免疫中药小分子药物多归属于多糖类、黄酮类、二酮类以及类黄酮化合物等,可通过调节机体固有免疫系统(包括巨噬细胞、树突状细胞、自然杀伤细胞和髓系抑制细胞等)、适应性免疫系统(包括T淋巴细胞、B细胞和调节性T细胞等)以及相关细胞因子[包括白细胞介素(Interleakin,IL)-2、IL-4、IL-6和肿瘤坏死因子-α(Tumor necrosis factor-α,TNF-α)等],直接或间接改善免疫细胞的活性,增加免疫细胞对肿瘤细胞的杀伤力,从而改善肿瘤免疫微环境,更好地发挥抗肿瘤作用。通过收集近年来中药小分子药物在抗肿瘤免疫领域的相关研究,从中药小分子药物调节免疫细胞作用机制角度进行论述,以期为中医药治疗肿瘤提供新的理论基础,有助于实现中医药在肿瘤治疗中的现代化之路。
Research Progress on Mechanism of Small Molecule Drugs in Traditional Chinese Medicine in Anti-Tumor Immunity
Tumor immunotherapy has become a new type of anti-tumor therapy with the most potential at present,and the combination of immunotherapy with chemotherapy and targeting has become the first-line treatment for a variety of malignant tumors.Traditional Chinese medicine(TCM)plays an important role in the comprehensive treatment of tumor.It can play an anti-tumor role by increasing the number of immune cells,improving the activity of immune cells and improving the immune microenvi-ronment of tumor.There are a wide variety of TCM small molecule drugs,which have the characteristics of multi-target,multi-pathway and extensive pharmacological action and so on and are the hot research field of many oncologists at present.A large number of studies have found that TCM small molecule drugs for anti-tumor immunity are mostly classified into polysaccharide,flavonoid,diketone and flavonoid compounds,etc.The activity of immune cells can be improved directly or indirectly by regula-ting the innate immune system(including macrophages,dendritic cells,natural killer cells and myeloid suppressor cells,etc.),the adaptive immune system(including T lymphocytes,B cells and regulatory T cells,etc.)and related cytokines[including interleu-kin-2(IL-2),interleukin-4(IL-4),interleukin-6(IL-6)and tumor necrosis factor-α(TNF-α),etc.]and increasing the lethality of immune cells to tumor cells,so as to improve the tumor immune microenvironment and better play the anti-tumor role.Based on the collection of recent studies on the role of TCM small molecule drugs in the field of anti-tumor immunity,this paper discussed the mechanism of TCM small molecule drugs in regulating immune cells,with a view to providing a new theoretical basis for the treatment of tumor by TCM and helping to realize the modernization of TCM in the treatment of tumor.

TCM small molecule drugstumor immunitystudy on mechanism

王成志、张晓青、刘一帆、朱甜甜、刘培民、李东东

展开 >

河南中医药大学第二附属医院,河南郑州 450002

郑州大学第一附属医院,河南郑州 450052

中药小分子药物 肿瘤免疫 机制研究

国家自然科学基金青年科学基金项目河南省中医药科学研究专项河南省中医药科学研究专项河南省中医药科学研究专项河南省中医院博士科研基金项目

822049812021JDZX20022019JDZX03320-21ZY2115

2024

中华中医药学刊
中华中医药学会 ,辽宁中医药大学

中华中医药学刊

CSTPCD北大核心
影响因子:1.007
ISSN:1673-7717
年,卷(期):2024.42(2)
  • 1
  • 53